ORBIMED ADVISORS LLC Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for ORBIMED ADVISORS LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of ORBIMED ADVISORS LLC. ORBIMED ADVISORS LLC is Director in INSULET CORP ($PODD) and 10% Owner in CRYOCOR INC ($CRYO) and Director in CRYOCOR INC ($CRYO) and 10% Owner in Anthera Pharmaceuticals Inc ($ANTH) and Director in Biodel Inc ($BIOD) and Director in NxStage Medical, Inc. ($NXTM) and Director in ATHERSYS, INC / NEW ($ATHX) and 10% Owner in ARYx Therapeutics, Inc. ($ARYX) and Director in ARYx Therapeutics, Inc. ($ARYX).
Latest Insider Trading Transactions of ORBIMED ADVISORS LLC
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ALBO, ANTH, ARYX, ATHX, CRYO, PODD, NXTM
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Dec 13 2010 | NXTM | NxStage Medical, I ... | ORBIMED ADVISORS LLC | Director | Sell | S | 22.60 | 2,356 | 53,255 | 0 | 2.4 K to 0 (-100.00 %) |
Oct 15 2010 | NXTM | NxStage Medical, I ... | ORBIMED ADVISORS LLC | Director | Buy | J | 0.00 | 2,356 | 0 | 2,356 | 0 to 2.4 K |
Oct 15 2010 | NXTM | NxStage Medical, I ... | ORBIMED ADVISORS LLC | Director | Sell | J | 0.00 | 1,009,524 | 0 | 2,690,476 | 3.7 M to 2.7 M (-27.28 %) |
Oct 04 2010 | ANTH | Anthera Pharmaceut ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | P | 4.08 | 19,900 | 81,192 | 3,449,734 | 3.4 M to 3.4 M (+0.58 %) |
Sep 17 2010 | NXTM | NxStage Medical, I ... | ORBIMED ADVISORS LLC | Director | Sell | S | 16.23 | 54,000 | 876,420 | 3,700,000 | 3.8 M to 3.7 M (-1.44 %) |
Sep 14 2010 | NXTM | NxStage Medical, I ... | ORBIMED ADVISORS LLC | Director | Sell | S | 16.49 | 96,000 | 1,583,040 | 3,754,000 | 3.9 M to 3.8 M (-2.49 %) |
Sep 14 2010 | NXTM | NxStage Medical, I ... | ORBIMED ADVISORS LLC | Director | Sell | S | 16.70 | 100,000 | 1,670,000 | 3,850,000 | 4 M to 3.9 M (-2.53 %) |
Sep 14 2010 | NXTM | NxStage Medical, I ... | ORBIMED ADVISORS LLC | Director | Sell | S | 16.52 | 193,900 | 3,203,228 | 3,950,000 | 4.1 M to 4 M (-4.68 %) |
Sep 09 2010 | NXTM | NxStage Medical, I ... | ORBIMED ADVISORS LLC | Director | Sell | S | 16.36 | 8,800 | 143,968 | 4,143,900 | 4.2 M to 4.1 M (-0.21 %) |
Sep 09 2010 | NXTM | NxStage Medical, I ... | ORBIMED ADVISORS LLC | Director | Sell | S | 16.50 | 7,000 | 115,500 | 4,152,700 | 4.2 M to 4.2 M (-0.17 %) |
Sep 09 2010 | NXTM | NxStage Medical, I ... | ORBIMED ADVISORS LLC | Director | Sell | S | 16.79 | 40,100 | 673,279 | 4,159,700 | 4.2 M to 4.2 M (-0.95 %) |
Aug 18 2010 | NXTM | NxStage Medical, I ... | ORBIMED ADVISORS LLC | Director | Sell | S | 16.94 | 100,200 | 1,697,388 | 4,199,800 | 4.3 M to 4.2 M (-2.33 %) |
Aug 18 2010 | NXTM | NxStage Medical, I ... | ORBIMED ADVISORS LLC | Director | Sell | S | 17.06 | 288,000 | 4,913,280 | 4,300,000 | 4.6 M to 4.3 M (-6.28 %) |
Aug 18 2010 | NXTM | NxStage Medical, I ... | ORBIMED ADVISORS LLC | Director | Sell | S | 17.11 | 112,000 | 1,916,320 | 4,588,000 | 4.7 M to 4.6 M (-2.38 %) |
Aug 04 2010 | NXTM | NxStage Medical, I ... | ORBIMED ADVISORS LLC | Director | Sell | S | 16.31 | 101,100 | 1,648,779 | 4,700,000 | 4.8 M to 4.7 M (-2.11 %) |
Aug 04 2010 | NXTM | NxStage Medical, I ... | ORBIMED ADVISORS LLC | Director | Sell | S | 16.41 | 199,200 | 3,269,370 | 4,801,100 | 5 M to 4.8 M (-3.98 %) |
Aug 04 2010 | NXTM | NxStage Medical, I ... | ORBIMED ADVISORS LLC | Director | Sell | S | 16.39 | 17,400 | 285,101 | 5,000,300 | 5 M to 5 M (-0.35 %) |
Jul 29 2010 | NXTM | NxStage Medical, I ... | ORBIMED ADVISORS LLC | Director | Sell | S | 16.66 | 128,000 | 2,131,942 | 5,017,700 | 5.1 M to 5 M (-2.49 %) |
Jul 29 2010 | NXTM | NxStage Medical, I ... | ORBIMED ADVISORS LLC | Director | Sell | S | 16.93 | 572,556 | 9,691,312 | 5,145,700 | 5.7 M to 5.1 M (-10.01 %) |
Jan 12 2010 | ATHX | ATHERSYS, INC / NE ... | ORBIMED ADVISORS LLC | Director | Sell | J | 0.00 | 4,947 | 0 | 1,805,100 | 1.8 M to 1.8 M (-0.27 %) |
Jan 12 2010 | ATHX | ATHERSYS, INC / NE ... | ORBIMED ADVISORS LLC | Director | Sell | J | 0.00 | 1,800,153 | 0 | 1,810,047 | 3.6 M to 1.8 M (-49.86 %) |
Jun 11 2009 | BIOD | Biodel Inc | ORBIMED ADVISORS LLC | Director | Option Exercise | A | 14.12 | 10,000 | 141,200 | 10,000 | |
Jun 11 2009 | BIOD | Biodel Inc | ORBIMED ADVISORS LLC | Director | Sell | S | 5.24 | 26,988 | 141,417 | 1,485,904 | 1.5 M to 1.5 M (-1.78 %) |
Jun 11 2009 | BIOD | Biodel Inc | ORBIMED ADVISORS LLC | Director | Sell | J | 0.00 | 300,000 | 0 | 1,512,892 | 1.8 M to 1.5 M (-16.55 %) |
May 26 2009 | ARYX | ARYx Therapeutics, ... | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | P | 2.64 | 364,395 | 962,003 | 364,395 | |
May 26 2009 | ARYX | ARYx Therapeutics, ... | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 4.00 | 2,000,000 | 8,000,000 | 1,340,139 | 3.3 M to 1.3 M (-59.88 %) |
Mar 18 2009 | ATHX | ATHERSYS, INC / NE ... | ORBIMED ADVISORS LLC | Director | Buy | P | 0.84 | 110,000 | 92,400 | 3,610,200 | 3.5 M to 3.6 M (+3.14 %) |
Mar 18 2009 | ATHX | ATHERSYS, INC / NE ... | ORBIMED ADVISORS LLC | Director | Buy | P | 0.65 | 52,200 | 33,930 | 3,500,200 | 3.4 M to 3.5 M (+1.51 %) |
Nov 18 2008 | ARYX | ARYx Therapeutics, ... | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | P | 2.64 | 364,395 | 962,003 | 364,395 | |
Nov 18 2008 | ARYX | ARYx Therapeutics, ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | P | 0.00 | 1,214,646 | 0 | 3,340,139 | 2.1 M to 3.3 M (+57.15 %) |
Aug 28 2008 | NXTM | NxStage Medical, I ... | ORBIMED ADVISORS LLC | Director | Option Exercise | A | 4.36 | 11,667 | 50,868 | 11,667 | |
Aug 28 2008 | NXTM | NxStage Medical, I ... | ORBIMED ADVISORS LLC | Director | Option Exercise | P | 5.50 | 1,111,111 | 6,111,111 | 1,111,111 | |
Aug 28 2008 | NXTM | NxStage Medical, I ... | ORBIMED ADVISORS LLC | Director | Buy | P | 3.50 | 27,700 | 97,052 | 5,718,256 | 5.7 M to 5.7 M (+0.49 %) |
Aug 25 2008 | NXTM | NxStage Medical, I ... | ORBIMED ADVISORS LLC | Director | Option Exercise | A | 4.36 | 11,667 | 50,868 | 11,667 | |
Aug 25 2008 | NXTM | NxStage Medical, I ... | ORBIMED ADVISORS LLC | Director | Option Exercise | P | 5.50 | 1,111,111 | 6,111,111 | 1,111,111 | |
Aug 25 2008 | NXTM | NxStage Medical, I ... | ORBIMED ADVISORS LLC | Director | Buy | P | 3.37 | 108,900 | 367,113 | 5,690,556 | 5.6 M to 5.7 M (+1.95 %) |
Aug 25 2008 | NXTM | NxStage Medical, I ... | ORBIMED ADVISORS LLC | Director | Buy | P | 3.25 | 26,100 | 84,833 | 5,581,656 | 5.6 M to 5.6 M (+0.47 %) |
May 23 2008 | ATHX | ATHERSYS, INC / NE ... | ORBIMED ADVISORS LLC | Director | Option Exercise | P | 6.00 | 750,000 | 4,500,000 | 750,000 | |
May 23 2008 | ATHX | ATHERSYS, INC / NE ... | ORBIMED ADVISORS LLC | Director | Option Exercise | A | 5.00 | 75,000 | 375,000 | 75,000 | |
May 23 2008 | ATHX | ATHERSYS, INC / NE ... | ORBIMED ADVISORS LLC | Director | Buy | P | 2.40 | 268,000 | 643,200 | 3,448,000 | 3.2 M to 3.4 M (+8.43 %) |
May 21 2008 | ATHX | ATHERSYS, INC / NE ... | ORBIMED ADVISORS LLC | Director | Option Exercise | P | 6.00 | 750,000 | 4,500,000 | 750,000 | |
May 21 2008 | ATHX | ATHERSYS, INC / NE ... | ORBIMED ADVISORS LLC | Director | Option Exercise | A | 5.00 | 75,000 | 375,000 | 75,000 | |
May 21 2008 | ATHX | ATHERSYS, INC / NE ... | ORBIMED ADVISORS LLC | Director | Buy | P | 2.40 | 130,000 | 312,000 | 3,180,000 | 3.1 M to 3.2 M (+4.26 %) |
May 15 2008 | ATHX | ATHERSYS, INC / NE ... | ORBIMED ADVISORS LLC | Director | Option Exercise | P | 6.00 | 750,000 | 4,500,000 | 750,000 | |
May 15 2008 | ATHX | ATHERSYS, INC / NE ... | ORBIMED ADVISORS LLC | Director | Option Exercise | A | 5.00 | 75,000 | 375,000 | 75,000 | |
May 15 2008 | ATHX | ATHERSYS, INC / NE ... | ORBIMED ADVISORS LLC | Director | Buy | P | 2.40 | 50,000 | 120,000 | 3,050,000 | 3 M to 3.1 M (+1.67 %) |
Feb 14 2008 | BIOD | Biodel Inc | ORBIMED ADVISORS LLC | Director | Sell | S | 14.48 | 154,000 | 2,229,920 | 1,812,892 | 2 M to 1.8 M (-7.83 %) |
Nov 15 2007 | ARYX | ARYx Therapeutics, ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 323,399 | 0 | 0 | |
Nov 15 2007 | ARYX | ARYx Therapeutics, ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 604,228 | 0 | 0 | |
Nov 15 2007 | ARYX | ARYx Therapeutics, ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 897,866 | 0 | 0 | |
Nov 15 2007 | ARYX | ARYx Therapeutics, ... | ORBIMED ADVISORS LLC | Director | Buy | P | 10.00 | 300,000 | 3,000,000 | 2,125,493 | 1.8 M to 2.1 M (+16.43 %) |
Nov 15 2007 | ARYX | ARYx Therapeutics, ... | ORBIMED ADVISORS LLC | Director | Buy | C | 0.00 | 1,825,493 | 0 | 1,825,493 | 0 to 1.8 M |
May 18 2007 | PODD | INSULET CORP | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 1,568,841 | 0 | 0 | |
May 18 2007 | PODD | INSULET CORP | ORBIMED ADVISORS LLC | Director | Buy | C | 0.00 | 1,568,841 | 0 | 1,568,841 | 0 to 1.6 M |
Jun 19 2007 | CRYO | CRYOCOR INC | ORBIMED ADVISORS LLC | 10% Owner | Sell | J | 0.00 | 842,504 | 0 | 389,432 | 1.2 M to 389.4 K (-68.39 %) |
Jun 12 2007 | ATHX | ATHERSYS, INC / NE ... | ORBIMED ADVISORS LLC | Director | Option Exercise | P | 6.00 | 750,000 | 4,500,000 | 750,000 | |
Jun 12 2007 | ATHX | ATHERSYS, INC / NE ... | ORBIMED ADVISORS LLC | Director | Option Exercise | A | 5.00 | 75,000 | 375,000 | 75,000 | |
Jun 12 2007 | ATHX | ATHERSYS, INC / NE ... | ORBIMED ADVISORS LLC | Director | Buy | P | 5.00 | 3,000,000 | 15,000,000 | 3,000,000 | 0 to 3 M |
Jul 18 2005 | CRYO | CRYOCOR INC | ORBIMED ADVISORS LLC | Director | Buy | S | 11.00 | 135,000 | 1,485,000 | 1,231,936 | 1.1 M to 1.2 M (+12.31 %) |
Page: 1